By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Grifols 

4560 Horton Street

Emeryville  California  94608  U.S.A.
Phone: 510-655-8730 Fax: n/a


SEARCH JOBS

Grifols is a global healthcare company celebrating more than 75 years of improving the health and well-being of people around the world. An experienced and trusted partner, the Grifols Diagnostic Division advances patient care with innovative solutions that improve disease detection and management and simplify laboratory operations. We empower customers with diagnostic products that span the healthcare continuum – from prevention, screening, diagnosis, and prognosis to disease and treatment monitoring.

Our comprehensive Transfusion Medicine portfolio is designed to support safety from donation through transfusion. We also offer a growing portfolio of specialized clinical diagnostics designed to detect and monitor treatment of infectious, autoimmune, and neurodegenerative diseases.



Key Statistics


Email:
Ownership: Public

Web Site: Grifols
Employees: 14,700
Symbol: GRFS
 



Industry
Healthcare






Company News
Grifols (GRFS) Phocus Rx Pharmacy Workflow Management Solution Now Integrates With Top Hospital Information Systems via HL7 Interfaces 8/22/2017 11:19:50 AM
Grifols (GRFS) Continues To Strengthen Its Diagnostic Division By Launching New Global Testing Services For The Measurement Of Biological Drug Levels And Anti-Drug Immune Response In Blood Samples 6/23/2017 8:48:09 AM
Grifols (GRFS) And Beckman Coulter (BEC) Enter Into An Exclusive Distribution Agreement 6/12/2017 6:54:23 AM
Investigational New Drug Application Is Now Effective For Babesia Screening In Blood Donations Using Grifols (GRFS) Procleix Panther System In The U.S. 5/9/2017 8:17:32 AM
Grifols (GRFS) Strengthens Position As Global Provider Of Diagnostic Testing Solutions With Five-Year Extension Of OraSure Tech (OSUR) Agreement And A New Manufacturing Facility 4/24/2017 11:15:49 AM
Grifols (GRFS) 2016 Annual Report On Form 20-F Filed With The SEC On April 4, 2017 4/4/2017 10:28:34 AM
Grifols (GRFS) Closes The Acquisition Of Hologic (HOLX)'s Share Of NAT Donor Screening Unit For USD 1,850 Million 2/1/2017 7:52:37 AM
The CLIA Lab At The Grifols Immunohematology Center Will Now Offer Both Serology And Molecular Tests 10/21/2016 11:14:59 AM
Grifols (GRFS) Opens Diagnostic Training Center In Dubai 9/6/2016 8:20:22 AM
FDA Approves Use Of The Procleix Zika Virus Assay From Hologic (HOLX) And Grifols (GRFS) To Screen The U.S. Blood Supply Under An IND Study Protocol 6/20/2016 6:40:00 AM
1234567
//-->